Approval · Notice of Compliance 1140 · 2000
AROMASIN TABLETS: Notice of Compliance 1140
Issued August 17, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1140
- Date
- August 17, 2000
- Company
- Pharmacia & Upjohn Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Aromatase inactivator; anti-tumour agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AROMASIN TABLETS | 02242705 | Marketed |
Medicinal ingredients
- EXEMESTANE 25 MG per TAB